Cargando…

Non-invasive serum fibrosis markers: A study in chronic hepatitis

[Image: see text] Introduction: Chronic hepatitis is specified as inflammatory disease of the liver lasting for more than six months. Role of noninvasive fibrosis markers as prognostication factors of the presence or absence of significant fibrosis on liver biopsy of patients with chronic hepatitis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdollahi, Mohammadreza, Pouri, Aliasghar, Ghojazadeh, Morteza, Estakhri, Rasoul, Somi, Mohammadhossein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tabriz University of Medical Sciences 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401163/ https://www.ncbi.nlm.nih.gov/pubmed/25901293 http://dx.doi.org/10.15171/bi.2015.05

Ejemplares similares

Tacrolimus and mycophenolate mofetil as second-line treatment in autoimmune hepatitis: Is the evidence of sufficient quality to develop recommendations?
por: Abdollahi, Mohammadreza, et al.
Publicado: (2020)

Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B
por: Montazeri, Ghodrat, et al.
Publicado: (2005)

Seroepidemiology and Risk Factors of Hepatitis B Virus Infection: A Population-Based Azar Cohort Study
por: POURI, Ali Asghar, et al.
Publicado: (2020)

Prevalence of hepatitis D virus among HBsAg-positive individuals, 2015-2016: Azar cohort study
por: Pouri, Ali Asghar, et al.
Publicado: (2020)

Seroepidemiology and risk factors of hepatitis C virus infection in East Azerbaijan, Iran: a population-based Azar Cohort study
por: Pouri, Ali Asghar, et al.
Publicado: (2019)

Non-Invasive markers for hepatic fibrosis
por: Baranova, Ancha, et al.
Publicado: (2011)

Serum Level of Interleukin-6 in Patients with Oral Tongue Squamous cell Carcinoma
por: Lotfi, Alireza, et al.
Publicado: (2015)

Are non‐invasive fibrosis markers for chronic hepatitis B reliable in sub‐Saharan Africa?
por: Desalegn, Hailemichael, et al.
Publicado: (2017)

The effects of milk thistle on hepatic fibrosis due to methotrexate in rat
por: Ghaffari, Ali Reza, et al.
Publicado: (2011)

Efficacy of an Iranian herbal preparation (Lax-Asab) in treating functional constipation: A randomized, placebo-controlled clinical trial
por: Somi, Mohammad Hossein, et al.
Publicado: (2015)

Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis C
por: Paranaguá-Vezozzo, Denise C, et al.
Publicado: (2017)

Serum Hyaluronic Acid: A Promising Marker of Hepatic Fibrosis in Chronic Hepatitis B
por: Shiha, Gamal
Publicado: (2008)

Serum Hyaluronic Acid as a Noninvasive Marker of Hepatic Fibrosis in Chronic Hepatitis B
por: Geramizadeh, Bita, et al.
Publicado: (2008)

Liver Shear-Wave Velocity and Serum Fibrosis Markers to Diagnose Hepatic Fibrosis in Patients with Chronic Viral Hepatitis B
por: Liu, Jianxue, et al.
Publicado: (2016)

Contribution of the ELFG Test in Algorithms of Non-Invasive Markers towards the Diagnosis of Significant Fibrosis in Chronic Hepatitis C
por: Zarski, Jean-Pierre, et al.
Publicado: (2013)

Serum ferritin as a non‐invasive marker in the prediction of hepatic fibrosis among Egyptian patients with non‐alcoholic fatty liver disease
por: El Nakeeb, Noha, et al.
Publicado: (2017)

Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B
por: Poynard, Thierry, et al.
Publicado: (2011)

Hepatitis C and pulmonary fibrosis: Hepatitis C and pulmonary fibrosis
por: Aliannejad, Rasoul, et al.
Publicado: (2011)

The Evaluation of Effective Drugs for the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis
por: Jalili, Ramin, et al.
Publicado: (2020)

Systematic review and individual-patient-data meta-analysis of non-invasive fibrosis markers for chronic hepatitis B in Africa
por: Johannessen, Asgeir, et al.
Publicado: (2023)

Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis
por: Moriya, Kei, et al.
Publicado: (2021)

Analysis of hepatic fibrosis markers in the serum of chronic hepatitis B patients according to basal core promoter/precore mutants
por: Lefeuvre, Caroline, et al.
Publicado: (2022)

Gender Differences in Clinical Presentations of Cystic Fibrosis Patients in Azeri Turkish Population
por: Vahedi, Leila, et al.
Publicado: (2016)

Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C
por: Przekop, Dagmara, et al.
Publicado: (2021)

Hepatic steatosis and fibrosis: Non-invasive assessment
por: Karanjia, Rustam N, et al.
Publicado: (2016)

Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?
por: Oztas, Erkin, et al.
Publicado: (2015)

Serum Fibrosis Markers for the Diagnosis of Liver Disease Among People With Chronic Hepatitis C in Chennai, India
por: Cepeda, Javier A., et al.
Publicado: (2016)

Serum markers for predicting advanced fibrosis in patients with chronic hepatitis B and nonalcoholic fatty liver disease
por: Wang, Qi, et al.
Publicado: (2021)

Usefulness of Non-invasive Markers for Predicting Significant Fibrosis in Patients with Chronic Liver Disease
por: Lee, Han Hyo, et al.
Publicado: (2010)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
por: Chen, Qingling, et al.
Publicado: (2023)

Retrospective Evaluation of Non-Invasive Assessment Based on Routine Laboratory Markers for Assessing Advanced Liver Fibrosis in Chronic Hepatitis B Patients
por: Wang, Zeyu, et al.
Publicado: (2022)

Non invasive assessment of liver fibrosis in chronic hemodialysis patients with viral hepatitis C
por: Arrayhani, Mohamed, et al.
Publicado: (2015)

The Safety and Side Effects of Amide-Based Local Anesthetics in Rats with Acetaminophen-Induced Hepatic Injury
por: Gheisari, Rasoul, et al.
Publicado: (2020)

Mac-2 Binding Protein Glycosylation Isomer: Emerging Non-Invasive Serum Marker for Liver Fibrosis
por: Cho, Sun Young, et al.
Publicado: (2018)

Non-Invasive Histologic Markers of Liver Disease in Patients With Chronic Hepatitis B
por: Shoaei, Simin Dokht, et al.
Publicado: (2014)

The Association between Non-Invasive Hepatic Fibrosis Markers and Cardiometabolic Risk Factors in the Framingham Heart Study
por: Long, Michelle T., et al.
Publicado: (2016)

Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?: Erratum
Publicado: (2015)

Serum Gamma-Glutamyl Transpeptidase-to-Platelet Ratio as a Noninvasive Marker of Liver Fibrosis in Chronic Hepatitis B
por: Purkayastha, Subham, et al.
Publicado: (2023)

Serum viral markers in Iranian patients with congenital bleeding disorder
por: Nassirtoosi, Mohssen, et al.
Publicado: (2008)

The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C
por: Lee, Jia-Jung, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0g9emqjjqnejd7i4n53aa0i0li